About Us
1919
Established
October 12
Milestones
¥997.3bn
Consolidated Revenue
March 2025
Company Outline
100
Diseases or Conditions Treated
*As of April 2025
Facts & Figures
40
Countries or Regions
*As of March 2025
Worldwide Office Locations
-
Corporate Philosophy and Management Policy
-
Company Profile
-
Corporate Governance
-
Worldwide Office Locations
-
Milestones
-
True to Life
Helping people live the life they want to live. Making people’s lives healthier, safer and more fulfilling.
-
Company Presentation
See our company video and presentation PDF.
News
- Dec. 05, 2025 CorporateOlympus, Gore, and ConMed Announce Transition of Commercial Support for the GORE® VIABIL® Biliary Endoprosthesis in the United States
- Dec. 02, 2025 CorporateSwan EndoSurgical Appoints Veteran Robotics and MedTech Leader Erik Todd as Chief Executive Officer
- Oct. 21, 2025 CorporateOlympus: Feasibility Study on Endoscopy Infection Control Systems in India Selected for METI’s “Global South Co-Creation Subsidy Program”
- Oct. 14, 2025 CorporateA new “True to Life Story” featuring the fight with cancer of former WBA champion Shinji Takehara
- Oct. 06, 2025 CorporateOlympus and W. L. Gore & Associates Enter into International Distribution Agreement to Expand the Olympus EndoTherapy Portfolio